Related Experiment Video
Updated: Jan 1, 2026

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
Published on: June 8, 2014
Pharmacogenomics in medication-related osteonecrosis of the jaw: a systematic literature review
N Bastida-Lertxundi1, I O Leizaola-Cardesa, J Hernando-Vázquez
1Department of Genetics, Donostia University Hospital, San Sebastian, Spain. ggomez@ugr.es.
Objective:
Medication-related osteonecrosis of the jaw (ONJ) is an adverse, severe and debilitating effect, which although infrequent, affects patients with osteoporosis or neoplasm who take bisphosphonates, antiresorptive drugs, and/or antiangiogenic drugs. Its etiopathogenesis is unknown, although genetic causes have been postulated.
Materials And Methods:
This review analyzed articles published to date that have studied genetic factors associated with ONJ. Fifteen case-control studies were included, published between 2008 and 2018.
Results:
Five set out to determine genetic causes by means of genome-centered techniques, while ten do so by investigating gene-centered variants. Nine works found statistically significant associations between one or various single nucleotide polymorphisms (SNPs) and the appearance of ONJ. None of the studies coincided as to which genes present some association.
Conclusions:
The review observed the moderate impact of genetic factors on the appearance of ONJ. It also showed the heterogeneity of the studies that have investigated ONJ to date. In future studies, involving international and interhospital collaboration will be necessary to recruit sample sizes of sufficient size, elaborate adequate study designs, obtain clear results, and advance our understanding of ONJ and make it possible to single out individual patients at risk.
Insights
Genetic factors moderately impact medication-related osteonecrosis of the jaw (ONJ). While studies found associations with single nucleotide polymorphisms (SNPs), further research with larger sample sizes is needed to clarify genetic contributions to ONJ.
Area of Science:
- Genetics
- Pharmacology
- Oral Medicine
Background:
- Medication-related osteonecrosis of the jaw (ONJ) is a severe adverse effect linked to bisphosphonates, antiresorptive, and antiangiogenic drugs.
- The exact causes of ONJ are unknown, but genetic factors are suspected.
- ONJ affects patients with osteoporosis or neoplasms.
Purpose of the Study:
- To review existing literature on genetic factors associated with ONJ.
- To synthesize findings from case-control studies investigating genetic predispositions to ONJ.
Main Methods:
- A systematic review of articles published between 2008 and 2018.
- Inclusion of fifteen case-control studies focusing on genetic factors in ONJ.
- Analysis of studies using genome-centered and gene-centered approaches.
Main Results:
- Nine out of fifteen studies identified statistically significant associations between single nucleotide polymorphisms (SNPs) and ONJ.
- Studies employed diverse genetic techniques, including genome-centered and gene-centered variant investigations.
- No consensus was reached among studies regarding specific genes linked to ONJ.
Conclusions:
- Genetic factors appear to have a moderate influence on the development of ONJ.
- Significant heterogeneity exists in current research methodologies and findings.
- Future research necessitates international collaboration for larger sample sizes and robust study designs to advance ONJ understanding and patient risk stratification.
More Related Videos
07:20Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice
Published on: August 23, 2024
07:10Micro-Computed Tomography Analysis of the Knee in Aged Dunkin-Hartley Guinea Pigs after Intra Articular Injection
Published on: August 2, 2024
Related Concept Videos
Pharmacodynamics in Geriatric Patients: Effects of Age
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
Osteoclasts in Bone Remodeling
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion